Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- DOI
- 10.1093/ced/llag164
- Published
- 2026-04-15
- Container
- Clinical and Experimental Dermatology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ced/llag164,
title = {Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study},
author = {Marina Talamonti and Edoardo Mortato and Alessandra Narcisi and Silvia Mariel Ferrucci and Luigi Gargiulo and Angelo Valerio Marzano and Maddalena Napolitano and Cataldo Patruno and Mariateresa Rossi and Anna Balato and Niccolò Gori and Caterina Foti and Rossana Tiberio and Monica Corazza and Andrea Carugno and Laura Calabrese and Elena Pezzolo and Maria Esposito and Emiliano Antiga and Ilaria Trave and Paola Savoia and Francesca Caroppo and Martina Maurelli and Maria Letizia Musumeci and Paolo Amerio and Luca Stingeni and Serena Lembo and Rosanna Rita Satta and Filomena Russo and Maria Mariano and Claudia Paganini and Antonio Costanzo and Martina Zussino and Marika Del Gaudio and Erica Stevan and Stefano Caccavale and Alessandra D’Amore and Benedetta Tirone and Ginevra Pertusi and Alessandro Borghi and Laura Lazzeri and Lina Maria Magnanimi and Roberto Maglie and Emanuele Cozzani and Federica Veronese and Anna Belloni Fortina and Giampiero Girolomoni and Giuseppe Micali and Edvige Morea and Katharina Hansel and Annunziata Raimondo and Gabriele Biondi and Donatella Sordi and Luciano Ibba and Maddalena Nicoletti and Ketty Peris and Giorgia Sbarra and Natale Schettini and Alessia Loda and Elia Esposto and Barbara Cocuroccia and Maria Concetta Fargnoli and Nicola Zerbinati and Luca Bianchi and Marco Galluzzo},
year = {2026},
journal = {Clinical and Experimental Dermatology},
doi = {10.1093/ced/llag164},
url = {https://doi.org/10.1093/ced/llag164}
}RIS
TY - JOUR TI - Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study AU - Marina Talamonti AU - Edoardo Mortato AU - Alessandra Narcisi AU - Silvia Mariel Ferrucci AU - Luigi Gargiulo AU - Angelo Valerio Marzano AU - Maddalena Napolitano AU - Cataldo Patruno AU - Mariateresa Rossi AU - Anna Balato AU - Niccolò Gori AU - Caterina Foti AU - Rossana Tiberio AU - Monica Corazza AU - Andrea Carugno AU - Laura Calabrese AU - Elena Pezzolo AU - Maria Esposito AU - Emiliano Antiga AU - Ilaria Trave AU - Paola Savoia AU - Francesca Caroppo AU - Martina Maurelli AU - Maria Letizia Musumeci AU - Paolo Amerio AU - Luca Stingeni AU - Serena Lembo AU - Rosanna Rita Satta AU - Filomena Russo AU - Maria Mariano AU - Claudia Paganini AU - Antonio Costanzo AU - Martina Zussino AU - Marika Del Gaudio AU - Erica Stevan AU - Stefano Caccavale AU - Alessandra D’Amore AU - Benedetta Tirone AU - Ginevra Pertusi AU - Alessandro Borghi AU - Laura Lazzeri AU - Lina Maria Magnanimi AU - Roberto Maglie AU - Emanuele Cozzani AU - Federica Veronese AU - Anna Belloni Fortina AU - Giampiero Girolomoni AU - Giuseppe Micali AU - Edvige Morea AU - Katharina Hansel AU - Annunziata Raimondo AU - Gabriele Biondi AU - Donatella Sordi AU - Luciano Ibba AU - Maddalena Nicoletti AU - Ketty Peris AU - Giorgia Sbarra AU - Natale Schettini AU - Alessia Loda AU - Elia Esposto AU - Barbara Cocuroccia AU - Maria Concetta Fargnoli AU - Nicola Zerbinati AU - Luca Bianchi AU - Marco Galluzzo PY - 2026 JO - Clinical and Experimental Dermatology DO - 10.1093/ced/llag164 UR - https://doi.org/10.1093/ced/llag164 ER -
APA
Talamonti, M., Mortato, E., Narcisi, A., Ferrucci, S. M., Gargiulo, L., Marzano, A. V., Napolitano, M., Patruno, C., Rossi, M., Balato, A., Gori, N., Foti, C., Tiberio, R., Corazza, M., Carugno, A., Calabrese, L., Pezzolo, E., Esposito, M., Antiga, E., Trave, I., Savoia, P., Caroppo, F., Maurelli, M., Musumeci, M. L., Amerio, P., Stingeni, L., Lembo, S., Satta, R. R., Russo, F., Mariano, M., Paganini, C., Costanzo, A., Zussino, M., Gaudio, M. D., Stevan, E., Caccavale, S., D’Amore, A., Tirone, B., Pertusi, G., Borghi, A., Lazzeri, L., Magnanimi, L. M., Maglie, R., Cozzani, E., Veronese, F., Fortina, A. B., Girolomoni, G., Micali, G., Morea, E., Hansel, K., Raimondo, A., Biondi, G., Sordi, D., Ibba, L., Nicoletti, M., Peris, K., Sbarra, G., Schettini, N., Loda, A., Esposto, E., Cocuroccia, B., Fargnoli, M. C., Zerbinati, N., Bianchi, L., & Galluzzo, M. (2026). Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag164
Source records
- crossref · retrieved 2026-09-25T12:01:18.818Z